US Stock MarketDetailed Quotes

KRON Kronos Bio

Watchlist
  • 0.954
  • -0.004-0.41%
Trading Dec 23 14:29 ET
57.57MMarket Cap-0.67P/E (TTM)

Kronos Bio Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
45.23%-12.37M
34.75%-16.33M
-301.87%-23.9M
13.58%-78.58M
-11.08%-25.02M
-0.86%-22.59M
-11.12%-25.03M
74.68%-5.95M
22.89%-90.93M
61.51%-22.53M
Net income from continuing operations
55.03%-14.11M
45.53%-16.2M
-14.18%-29.96M
15.41%-112.67M
20.33%-25.32M
2.73%-31.37M
9.61%-29.74M
27.65%-26.24M
11.83%-133.2M
49.01%-31.78M
Depreciation and amortization
-19.22%412K
-27.46%420K
-16.52%475K
-5.74%2.14M
-16.72%478K
-10.68%510K
2.66%579K
2.15%569K
14.62%2.27M
5.13%574K
Other non cash items
-32.18%510K
0.88%803K
-0.88%790K
1.58%3.27M
25.75%928K
16.59%752K
-17.26%796K
-9.12%797K
24.45%3.22M
-17.17%738K
Change In working capital
-128.48%-740K
34.11%-3.29M
-163.32%-8.59M
-4.89%5.88M
-645.21%-5.29M
66.22%2.6M
-927.65%-5M
346.41%13.57M
481.36%6.18M
116.60%971K
-Change in prepaid assets
4,113.16%1.53M
60.29%1.65M
-264.23%-450K
-61.62%616K
-477.91%-650K
-106.23%-38K
147.00%1.03M
-32.51%274K
264.62%1.61M
104.50%172K
-Change in payables and accrued expense
-63.80%1.44M
41.12%-1.98M
11.16%-4.76M
-175.78%-6.18M
-190.66%-1.44M
50.40%3.98M
-542.24%-3.36M
-269.35%-5.36M
412.57%8.16M
251.38%1.59M
-Change in other current assets
----
----
--0
155.92%590K
137.25%393K
----
----
-100.00%-2K
-2,053.70%-1.06M
---1.06M
-Change in other current liabilities
----
----
-1,200.00%-65K
-129.17%-42K
----
----
----
97.85%-5K
106.24%144K
255.61%943K
-Change in other working capital
-140.74%-3.71M
-13.31%-3.03M
-117.77%-3.32M
507.79%10.89M
-427.89%-3.56M
-28.68%-1.54M
-430.75%-2.68M
6,384.18%18.66M
-14,157.89%-2.67M
-77.37%-674K
Cash from discontinued investing activities
Operating cash flow
45.23%-12.37M
34.75%-16.33M
-301.87%-23.9M
13.58%-78.58M
-11.08%-25.02M
-0.86%-22.59M
-11.12%-25.03M
74.68%-5.95M
22.89%-90.93M
61.51%-22.53M
Investing cash flow
Cash flow from continuing investing activities
-52.14%17.13M
647.60%40.18M
190.79%5.77M
305.97%66.37M
-0.55%31.56M
1,051.88%35.79M
113.19%5.37M
75.87%-6.36M
-150.56%-32.22M
-18.10%31.74M
Net PPE purchase and sale
103.27%7K
--0
94.44%-7K
-17.68%-679K
40.38%-31K
-193.15%-214K
-258.14%-308K
65.57%-126K
86.46%-577K
89.12%-52K
Net investment purchase and sale
-52.44%17.12M
607.07%40.18M
192.74%5.78M
311.87%67.05M
-0.62%31.59M
1,032.17%36M
113.98%5.68M
76.01%-6.23M
-146.55%-31.65M
-18.96%31.79M
Cash from discontinued investing activities
Investing cash flow
-52.14%17.13M
647.60%40.18M
190.79%5.77M
305.97%66.37M
-0.55%31.56M
1,051.88%35.79M
113.19%5.37M
75.87%-6.36M
-150.56%-32.22M
-18.10%31.74M
Financing cash flow
Cash flow from continuing financing activities
-1K
-33.37%567K
126.68%191K
0
-80.92%851K
-168.19%-716K
Proceeds from stock option exercised by employees
---1K
----
----
-33.37%567K
126.68%191K
--0
----
----
-80.94%851K
-168.19%-716K
Cash from discontinued financing activities
Financing cash flow
---1K
-56.38%164K
--0
-33.37%567K
126.68%191K
--0
-8.29%376K
--0
-80.92%851K
-168.19%-716K
Net cash flow
Beginning cash position
55.60%72.23M
-26.60%48.22M
-14.93%66.35M
-61.06%78M
-14.22%59.63M
-47.35%46.42M
-56.49%65.7M
-61.06%78M
-19.89%200.3M
-68.26%69.51M
Current changes in cash
-63.97%4.76M
224.57%24.01M
-47.37%-18.13M
90.48%-11.65M
-20.78%6.73M
170.76%13.2M
69.33%-19.28M
75.04%-12.3M
-145.87%-122.3M
145.36%8.49M
End cash Position
29.12%76.99M
55.60%72.23M
-26.60%48.22M
-14.93%66.35M
-14.93%66.35M
-14.22%59.63M
-47.35%46.42M
-56.49%65.7M
-61.06%78M
-61.06%78M
Free cash flow
45.77%-12.36M
35.54%-16.33M
-293.64%-23.91M
13.38%-79.26M
-10.96%-25.06M
-1.48%-22.8M
-12.06%-25.33M
74.54%-6.07M
25.11%-91.5M
61.73%-22.58M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 45.23%-12.37M34.75%-16.33M-301.87%-23.9M13.58%-78.58M-11.08%-25.02M-0.86%-22.59M-11.12%-25.03M74.68%-5.95M22.89%-90.93M61.51%-22.53M
Net income from continuing operations 55.03%-14.11M45.53%-16.2M-14.18%-29.96M15.41%-112.67M20.33%-25.32M2.73%-31.37M9.61%-29.74M27.65%-26.24M11.83%-133.2M49.01%-31.78M
Depreciation and amortization -19.22%412K-27.46%420K-16.52%475K-5.74%2.14M-16.72%478K-10.68%510K2.66%579K2.15%569K14.62%2.27M5.13%574K
Other non cash items -32.18%510K0.88%803K-0.88%790K1.58%3.27M25.75%928K16.59%752K-17.26%796K-9.12%797K24.45%3.22M-17.17%738K
Change In working capital -128.48%-740K34.11%-3.29M-163.32%-8.59M-4.89%5.88M-645.21%-5.29M66.22%2.6M-927.65%-5M346.41%13.57M481.36%6.18M116.60%971K
-Change in prepaid assets 4,113.16%1.53M60.29%1.65M-264.23%-450K-61.62%616K-477.91%-650K-106.23%-38K147.00%1.03M-32.51%274K264.62%1.61M104.50%172K
-Change in payables and accrued expense -63.80%1.44M41.12%-1.98M11.16%-4.76M-175.78%-6.18M-190.66%-1.44M50.40%3.98M-542.24%-3.36M-269.35%-5.36M412.57%8.16M251.38%1.59M
-Change in other current assets ----------0155.92%590K137.25%393K---------100.00%-2K-2,053.70%-1.06M---1.06M
-Change in other current liabilities ---------1,200.00%-65K-129.17%-42K------------97.85%-5K106.24%144K255.61%943K
-Change in other working capital -140.74%-3.71M-13.31%-3.03M-117.77%-3.32M507.79%10.89M-427.89%-3.56M-28.68%-1.54M-430.75%-2.68M6,384.18%18.66M-14,157.89%-2.67M-77.37%-674K
Cash from discontinued investing activities
Operating cash flow 45.23%-12.37M34.75%-16.33M-301.87%-23.9M13.58%-78.58M-11.08%-25.02M-0.86%-22.59M-11.12%-25.03M74.68%-5.95M22.89%-90.93M61.51%-22.53M
Investing cash flow
Cash flow from continuing investing activities -52.14%17.13M647.60%40.18M190.79%5.77M305.97%66.37M-0.55%31.56M1,051.88%35.79M113.19%5.37M75.87%-6.36M-150.56%-32.22M-18.10%31.74M
Net PPE purchase and sale 103.27%7K--094.44%-7K-17.68%-679K40.38%-31K-193.15%-214K-258.14%-308K65.57%-126K86.46%-577K89.12%-52K
Net investment purchase and sale -52.44%17.12M607.07%40.18M192.74%5.78M311.87%67.05M-0.62%31.59M1,032.17%36M113.98%5.68M76.01%-6.23M-146.55%-31.65M-18.96%31.79M
Cash from discontinued investing activities
Investing cash flow -52.14%17.13M647.60%40.18M190.79%5.77M305.97%66.37M-0.55%31.56M1,051.88%35.79M113.19%5.37M75.87%-6.36M-150.56%-32.22M-18.10%31.74M
Financing cash flow
Cash flow from continuing financing activities -1K-33.37%567K126.68%191K0-80.92%851K-168.19%-716K
Proceeds from stock option exercised by employees ---1K---------33.37%567K126.68%191K--0---------80.94%851K-168.19%-716K
Cash from discontinued financing activities
Financing cash flow ---1K-56.38%164K--0-33.37%567K126.68%191K--0-8.29%376K--0-80.92%851K-168.19%-716K
Net cash flow
Beginning cash position 55.60%72.23M-26.60%48.22M-14.93%66.35M-61.06%78M-14.22%59.63M-47.35%46.42M-56.49%65.7M-61.06%78M-19.89%200.3M-68.26%69.51M
Current changes in cash -63.97%4.76M224.57%24.01M-47.37%-18.13M90.48%-11.65M-20.78%6.73M170.76%13.2M69.33%-19.28M75.04%-12.3M-145.87%-122.3M145.36%8.49M
End cash Position 29.12%76.99M55.60%72.23M-26.60%48.22M-14.93%66.35M-14.93%66.35M-14.22%59.63M-47.35%46.42M-56.49%65.7M-61.06%78M-61.06%78M
Free cash flow 45.77%-12.36M35.54%-16.33M-293.64%-23.91M13.38%-79.26M-10.96%-25.06M-1.48%-22.8M-12.06%-25.33M74.54%-6.07M25.11%-91.5M61.73%-22.58M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Heat List
US
Overall
Symbol
Price
% Chg

No Data